Evidence map›Paper›PMID 39930740›Full record

ArticleStatistics in medicine2025

Power and Sample Size Calculations for Cluster Randomized Hybrid Type 2 Effectiveness-Implementation Studies.

Melody A Owen, Geoffrey M Curran, Justin D Smith, Yacob Tedla, Chao Cheng, Donna Spiegelman

Abstract read
In one paragraph

Article in Statistics in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Methodological considerations for evaluating scale-up programmes in healthcare: a methods review.International journal for quality in health care : journal of the International Society for Quality in Health Care · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Melody A OwenCenter for Methods in Implementation and Prevention Science, Yale University, New Haven, Connecticut, USA.ORCID 0009-0001-1292-0731
Geoffrey M CurranDepartment of Psychiatry, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
Justin D SmithPopulation Health Sciences, University of Utah School of Medicine, Salt Lake City, Utah, USA.
Yacob TedlaDivision of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Chao ChengCenter for Methods in Implementation and Prevention Science, Yale University, New Haven, Connecticut, USA.ORCID 0000-0003-3234-5874
Donna SpiegelmanCenter for Methods in Implementation and Prevention Science, Yale University, New Haven, Connecticut, USA.

Funding

CTSA UM1 Program at University of UtahUM1TR004409 · NCATS · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI RACHEL HESS, Jennifer Juhl Majersik · 2023 to 2026
$21.9M
Community Intervention to Reduce CardiovascuLar Disease in Chicago (CIRCL-Chicago)UG3HL154297 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI DAVIS, PARIS, KHO, ABEL N. · 2020 to 2022
$3.1M
Training in Implementation Science Research and MethodsT32HL155000 · NHLBI · YALE UNIVERSITY · PI SPIEGELMAN, DONNA L, VELAZQUEZ, ERIC J · 2021 to 2025
$2.2M
NCATS NIH HHS UM1 TR004409NHLBI NIH HHS T32 HL155000NHLBI NIH HHS UG3 HL154297NHLBI NIH HHS UG3HL154297Training in Implementation Science Research Methods T32HL155000
6 · The paper itself

Abstract

Hybrid studies allow investigators to simultaneously study an intervention effectiveness outcome and an implementation research outcome. In particular, type 2 hybrid studies support research that places equal importance on both outcomes rather than focusing on one and secondarily on the other (i.e., type 1 and type 3 studies). Hybrid 2 studies introduce the statistical issue of multiple testing, complicated by the fact that they are typically also cluster randomized trials. Standard statistical methods do not apply in this scenario. Here, we describe the design methodologies available for validly powering hybrid type 2 studies and producing reliable sample size calculations in a cluster-randomized design with a focus on binary outcomes. Through a literature search, 18 publications were identified that included methods relevant to the design of hybrid 2 studies. Five methods were identified, two of which did not account for clustering but are extended in this article to do so, namely the combined outcomes approach and the single 1-degree of freedom combined test. Procedures for powering hybrid 2 studies using these five methods are described and illustrated using input parameters inspired by a study from the Community Intervention to Reduce CardiovascuLar Disease in Chicago (CIRCL-Chicago) Implementation Research Center. In this illustrative example, the intervention effectiveness outcome was controlled blood pressure, and the implementation outcome was reach. The conjunctive test resulted in higher power than the popular p value adjustment methods, and the newly extended combined outcomes and single 1-DF test were found to be the most powerful among all of the tests.

Indexed as

Randomized Controlled Trials as TopicCardiovascular DiseasesChicagoCluster AnalysisHumansResearch DesignSample Sizecluster‐randomized trialshybrid type 2implementation‐effectiveness studiesimplementation science

Identifiers

PMID39930740
PMCPMC13382974

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.